difference between sglt2 and glp 1 Cardiorenal Protection: Potential of Inhibitors GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes | Diabetes Therapy SGLT-2 Inhibitors and GLP-1 Agonists:

Patients with severe kidney disease (eGFR below 2030) Patients with recurrent UTIs or fungal infections Type 1 diabetes patients (unless specifically prescribed) Pregnant women References: Protective Influence of SGLT-2 Inhibitors Against Heart Failure PMC 2024 Clinical Evidence for Cardiovascular & Kidney Benefits PMC SGLT2 Inhibitors: Antidiabetic and Cardioprotective Effects PMC Emerging Horizons: SGLT-2 Inhibitors Beyond Diabetes PMC DPP-4 inhibitors, sulfonylureas, TZDs So far we have covered the star players Metformin, GLP-1 agonists, and SGLT2 inhibitors

This month, Katz Institute for Womens Health sat down with Berta Kadosh, DO , Internal Medicine & Weight Management Specialist

Optimise your environment: Keep your home at a comfortable temperature (typically 1821C as advised by NHS winter health guidance)

In the most recent GFAPS wave, nearly 20% of respondents said that they have not yet used the drugs, but they are considering using them this year

Some of the insulin travels to the hypothalamus area of the brain, deactivating sensations of hunger

The market is driven by the rising incidence of chronic conditions such as type 2 diabetes and obesity, increasing R&D activities for novel therapeutics, patent expiry, and the entry of generic alternatives